These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 24132248

  • 1. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
    Ghaleiha A, Ghyasvand M, Mohammadi MR, Farokhnia M, Yadegari N, Tabrizi M, Hajiaghaee R, Yekehtaz H, Akhondzadeh S.
    J Psychopharmacol; 2014 Jul; 28(7):677-85. PubMed ID: 24132248
    [Abstract] [Full Text] [Related]

  • 2. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A, Mohammadi E, Mohammadi MR, Farokhnia M, Modabbernia A, Yekehtaz H, Ashrafi M, Hassanzadeh E, Akhondzadeh S.
    Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
    [Abstract] [Full Text] [Related]

  • 3. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R, Ghajar A, Mesgarpour B, Afarideh M, Mohammadi MR, Akhondzadeh S.
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
    [Abstract] [Full Text] [Related]

  • 4. Acetylcholinesterase inhibitors for autistic spectrum disorders.
    Ure A, Cox GR, Haslam R, Williams K.
    Cochrane Database Syst Rev; 2023 Jun 01; 6(6):CD013851. PubMed ID: 37267443
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M, Mohammadi MR, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, Forghani S, Akhondzadeh S.
    Psychopharmacology (Berl); 2013 Jan 01; 225(1):51-9. PubMed ID: 22782459
    [Abstract] [Full Text] [Related]

  • 7. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V, Mohammadi MR, Ghanizadeh A, Sahraian A, Tabrizi M, Rezazadeh SA, Akhondzadeh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct 01; 34(7):1269-72. PubMed ID: 20637249
    [Abstract] [Full Text] [Related]

  • 8. Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Moazen-Zadeh E, Shirzad F, Karkhaneh-Yousefi MA, Khezri R, Mohammadi MR, Akhondzadeh S.
    J Child Adolesc Psychopharmacol; 2018 Feb 01; 28(1):82-89. PubMed ID: 28719227
    [Abstract] [Full Text] [Related]

  • 9. Risperidone in children with autism and serious behavioral problems.
    McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D, Research Units on Pediatric Psychopharmacology Autism Network.
    N Engl J Med; 2002 Aug 01; 347(5):314-21. PubMed ID: 12151468
    [Abstract] [Full Text] [Related]

  • 10. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
    Nikoo M, Radnia H, Farokhnia M, Mohammadi MR, Akhondzadeh S.
    Clin Neuropharmacol; 2015 Aug 01; 38(1):11-7. PubMed ID: 25580916
    [Abstract] [Full Text] [Related]

  • 11. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
    Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B, Ghanizadeh A, Raznahan M, Mohebbi-Rasa S, Rezazadeh SA, Forghani S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):32-6. PubMed ID: 19772883
    [Abstract] [Full Text] [Related]

  • 12. A prospective, open-label trial of galantamine in autistic disorder.
    Nicolson R, Craven-Thuss B, Smith J.
    J Child Adolesc Psychopharmacol; 2006 Oct 01; 16(5):621-9. PubMed ID: 17069550
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.
    Pediatrics; 2004 Nov 01; 114(5):e634-41. PubMed ID: 15492353
    [Abstract] [Full Text] [Related]

  • 15. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H, Moghaddam HS, Mohammadi MR, Akhondzadeh S.
    Clin Neuropharmacol; 2019 Nov 01; 42(6):189-196. PubMed ID: 31725473
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B.
    J Child Adolesc Psychopharmacol; 2015 Aug 01; 25(6):482-93. PubMed ID: 26262903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.